Antiviral activity of some benzo[g]quinazolines against coxsackievirus B4: biological screening and docking study

[1] Flodström M(2001)A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection Virology 281 205-215

[2] Horwitz MS(2020)Genetic adaptation of coxsackievirus B1 during persistent infection in pancreatic cells Microorganisms 8 1790-107

[3] Maday A(2002)An overview of the evolution of enterovirus 71 and its clinical and public health significance FEMS Microbiol Rev 26 91-1655

[4] Balakrishna D(2020)Efficient synthesis and docking studies of novel benzothiazole-based pyrimidinesulfonamide scaffolds as new antiviral agents and Hsp90α inhibitors ACS Omega 5 1640-833

[5] Rodriguez E(2021)Persistence of coxsackievirus B4 in pancreatic β cells disturbs insulin maturation, pattern of cellular proteins, and DNA methylation Microorganisms 9 1125-7785

[6] Sarvetnick N(2010)Antiviral drug resistance: mechanisms and clinical implications Infect Dis Clin 24 809-666

[7] Honkimaa A(2015)Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68 Antimicrob Agents Chemother 59 7782-5120

[8] Kimura B(2008)Coxsackievirus B4 infection of murine foetal thymus organ cultures J Med Virol 80 659-6543

[9] Sioofy-Khojine A-B(2007)Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients Proc Natl Acad Sci 104 5115-92

[10] Lin J(2005)Designed multiple ligands. An emerging drug discovery paradigm J Med Chem 48 6523-410

[1] Flodström M(2001)A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection Virology 281 205-215

[2] Horwitz MS(2020)Genetic adaptation of coxsackievirus B1 during persistent infection in pancreatic cells Microorganisms 8 1790-107

[3] Maday A(2002)An overview of the evolution of enterovirus 71 and its clinical and public health significance FEMS Microbiol Rev 26 91-1655

[4] Balakrishna D(2020)Efficient synthesis and docking studies of novel benzothiazole-based pyrimidinesulfonamide scaffolds as new antiviral agents and Hsp90α inhibitors ACS Omega 5 1640-833

[5] Rodriguez E(2021)Persistence of coxsackievirus B4 in pancreatic β cells disturbs insulin maturation, pattern of cellular proteins, and DNA methylation Microorganisms 9 1125-7785

[6] Sarvetnick N(2010)Antiviral drug resistance: mechanisms and clinical implications Infect Dis Clin 24 809-666

[7] Honkimaa A(2015)Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68 Antimicrob Agents Chemother 59 7782-5120

[8] Kimura B(2008)Coxsackievirus B4 infection of murine foetal thymus organ cultures J Med Virol 80 659-6543

[9] Sioofy-Khojine A-B(2007)Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients Proc Natl Acad Sci 104 5115-92

[10] Lin J(2005)Designed multiple ligands. An emerging drug discovery paradigm J Med Chem 48 6523-410